A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Hydroxypropyl cellulose
Pipotiazine
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Pipotiazine.
Hydroxypropyl cellulose
Molindone
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Molindone.
Hydroxypropyl cellulose
Aceprometazine
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Aceprometazine.
Hydroxypropyl cellulose
Acepromazine
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Acepromazine.
Hydroxypropyl cellulose
Periciazine
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Periciazine.
Hydroxypropyl cellulose
Methotrimeprazine
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Methotrimeprazine.
Hydroxypropyl cellulose
Lithium cation
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Lithium cation.
Hydroxypropyl cellulose
Paliperidone
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Paliperidone.
Hydroxypropyl cellulose
Alimemazine
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Alimemazine.
Hydroxypropyl cellulose
Chlorprothixene
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Chlorprothixene.
Hydroxypropyl cellulose
Aripiprazole
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Aripiprazole.
Hydroxypropyl cellulose
Acetophenazine
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Acetophenazine.
Hydroxypropyl cellulose
Mesoridazine
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Mesoridazine.
Hydroxypropyl cellulose
Perphenazine
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Perphenazine.
Hydroxypropyl cellulose
Lorpiprazole
The risk or severity of serotonin syndrome and neuroleptic malignant syndrome can be increased when Metoclopramide is combined with Lorpiprazole.
Hydroxypropyl cellulose
Teriflunomide
The serum concentration of Metoclopramide can be decreased when it is combined with Teriflunomide.
Hydroxypropyl cellulose
Deferasirox
The serum concentration of Metoclopramide can be increased when it is combined with Deferasirox.
Tolazamide
Relugolix
The serum concentration of Relugolix can be increased when it is combined with Saquinavir.
Tolazamide
Berotralstat
The serum concentration of Berotralstat can be increased when it is combined with Saquinavir.
Tolazamide
Pralsetinib
The serum concentration of Saquinavir can be increased when it is combined with Pralsetinib.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3